The global automated breast ultrasound market size was valued at USD 2.4 billion in 2025 and is projected to grow from USD 2.7 billion in 2026 to USD 7.3 billion by 2033, at a CAGR of 15.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% in 2025. The increasing prevalence of breast cancer owing to a rise in sedentary lifestyles, obesity, changes in eating habits, and rising alcohol consumption is expected to increase the risk of the disease. In addition, the demand for reliable identification of breast lesions in the early stage of cancer is encouraging major manufacturing companies to develop automated diagnosis methods. Furthermore, various other government initiatives and awareness programs are significant contributors to the growth of the market.
According to a report from the American Cancer Society, approximately 2.04 million people were diagnosed with cancer in 2025. In addition, a report published by the WHO in February 2025 noted about 3.2 million cases of breast cancer and 1.1 million deaths worldwide in 2024. The increase in breast cancer cases highlights the need for technologically advanced medical devices that facilitate easier and earlier detection compared to conventional methods. This demand is expected to drive growth in the market over the forecast period.
The survival rate for breast cancer is significantly higher when diagnosed in the early stages; however, it drops to around 25 percent when detected at later stages. An article from the Massachusetts Institute of Technology, published in July 2023, reported that MIT researchers have designed a wearable ultrasound device capable of detecting tumors at an early stage. Such technological advancements are likely to boost market growth further in the coming years.
Various initiatives by government institutions and companies have raised awareness about breast cancer among both men and women, positively impacting market growth. For example, the WHO launched a new roadmap for breast cancer to save 2.5 million lives from the disease by 2040. Similarly, the Ministry of Health and Family Welfare in India is providing financial assistance to individuals living below the poverty line who are suffering from diseases such as cancer through the Umbrella Scheme, Rashtriya Arogya Nidhi, and the Health Minister’s Discretionary Grant.
▪ Canada
▪ Mexico
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
▪ China
▪ India
▪ Australia
▪ South Korea
▪ Thailand
▪ Argentina
▪ Saudi Arabia
▪ UAE
▪ Kuwait
This product will be delivered within 1-3 business days.
According to a report from the American Cancer Society, approximately 2.04 million people were diagnosed with cancer in 2025. In addition, a report published by the WHO in February 2025 noted about 3.2 million cases of breast cancer and 1.1 million deaths worldwide in 2024. The increase in breast cancer cases highlights the need for technologically advanced medical devices that facilitate easier and earlier detection compared to conventional methods. This demand is expected to drive growth in the market over the forecast period.
The survival rate for breast cancer is significantly higher when diagnosed in the early stages; however, it drops to around 25 percent when detected at later stages. An article from the Massachusetts Institute of Technology, published in July 2023, reported that MIT researchers have designed a wearable ultrasound device capable of detecting tumors at an early stage. Such technological advancements are likely to boost market growth further in the coming years.
Various initiatives by government institutions and companies have raised awareness about breast cancer among both men and women, positively impacting market growth. For example, the WHO launched a new roadmap for breast cancer to save 2.5 million lives from the disease by 2040. Similarly, the Ministry of Health and Family Welfare in India is providing financial assistance to individuals living below the poverty line who are suffering from diseases such as cancer through the Umbrella Scheme, Rashtriya Arogya Nidhi, and the Health Minister’s Discretionary Grant.
Automated Breast Ultrasound Market Report Segmentation
This report forecasts revenue growth at global; regional; and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global automated breast ultrasound market report based on product, end use, and region:Product Outlook (Revenue, USD Million, 2021 - 2033)
- Automated Breast Volume Scanner
- Automated Breast Ultrasound (ABUS)
End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospital
- Diagnostics Imaging Laboratories
- Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
▪ Canada
▪ Mexico
- Europe
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
- Asia Pacific
▪ China
▪ India
▪ Australia
▪ South Korea
▪ Thailand
- Latin America
▪ Argentina
- MEA
▪ Saudi Arabia
▪ UAE
▪ Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Automated Breast Ultrasound Market Variables, Trends, & Scope
Chapter 4. Automated Breast Ultrasound Market: Product Estimates & Trend Analysis
Chapter 5. Automated Breast Ultrasound Market: End Use Estimates & Trend Analysis
Chapter 6. Automated Breast Ultrasound Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
- GE HealthCare
- Koninklijke Philips N.V.
- Siemens Healthcare Private Limited
- CANON MEDICAL SYSTEMS CORPORATION
- TELEMED Medical Systems srl
- Hologic Inc.
- SuperSonic Imagine
- Lunit Inc.
- Delphinus Medical Technologies
